понедельник, 28 марта 2016 г.

Stephens Reiterates Buy Rating for Trinity Biotech plc

Stephens Reiterates Buy Rating for Trinity Biotech plc


's stock had its "buy" rating reiterated by equities research analysts at Stephens in a research report issued on Saturday, MarketBeat reports. Several hedge funds and institutional investors recently made changes to their positions in TRIB.



from Biotech News